Literature DB >> 29471561

Nonalcoholic Fatty Liver Disease in Children.

Jake P Mann1, Luca Valenti2, Eleonora Scorletti3, Christopher D Byrne3,4,5, Valerio Nobili6,7.   

Abstract

Nonalcoholic steatohepatitis, a progressive form of nonalcoholic fatty liver disease (NAFLD), is one of the most common hepatic diseases in children who present with particular risk factors including obesity, sedentary lifestyle, and/or a predisposing genetic background. The worldwide prevalence of NAFLD in children is a worrying phenomenon because this disease is closely associated with the development of both cirrhosis and cardiometabolic syndrome in adulthood. To date, the etiopathogenesis of primary NAFLD in children is unknown. Understanding the pathogenetic mechanisms provides the basis to characterize early predictors of the disease and noninvasive diagnostic tools and to design novel specific treatments and possible management strategies. Despite a few clinical trials on the use of antioxidants combined with lifestyle intervention for NAFLD, no treatment exists for children with NAFLD. In this review, the authors provide an overview of current concepts in epidemiology, histological features, etiopathogenesis, diagnosis, and treatment of NAFLD in pediatric population. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Year:  2018        PMID: 29471561     DOI: 10.1055/s-0038-1627456

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  33 in total

Review 1.  Excess Body Weight and Metabolic (Dysfunction)-Associated Fatty Liver Disease (MAFLD).

Authors:  Elke Roeb
Journal:  Visc Med       Date:  2021-04-13

2.  Higher Levels of Plasma Hyaluronic Acid and N-terminal Propeptide of Type III Procollagen Are Associated With Lower Kidney Function in Children With Non-alcoholic Fatty Liver Disease.

Authors:  Antonella Mosca; Alessandro Mantovani; Annalisa Crudele; Nadia Panera; Donatella Comparcola; Rita De Vito; Marzia Bianchi; Christopher D Byrne; Giovanni Targher; Anna Alisi
Journal:  Front Pediatr       Date:  2022-06-06       Impact factor: 3.569

Review 3.  Nonalcoholic steatohepatitis: the role of peroxisome proliferator-activated receptors.

Authors:  Sven Francque; Gyongyi Szabo; Manal F Abdelmalek; Christopher D Byrne; Kenneth Cusi; Jean-François Dufour; Michael Roden; Frank Sacks; Frank Tacke
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-10-22       Impact factor: 46.802

Review 4.  NAFLD in children: new genes, new diagnostic modalities and new drugs.

Authors:  Valerio Nobili; Anna Alisi; Luca Valenti; Luca Miele; Ariel E Feldstein; Naim Alkhouri
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2019-07-05       Impact factor: 46.802

Review 5.  Is obesity related to the lung function of non-asthmatic children?

Authors:  Andrew Fretzayas; Maria Moustaki; Ioanna Loukou; Konstantinos Douros
Journal:  World J Clin Pediatr       Date:  2018-05-08

6.  Heightened Plasma Levels of Transforming Growth Factor Beta (TGF-β) and Increased Degree of Systemic Biochemical Perturbation Characterizes Hepatic Steatosis in Overweight Pediatric Patients: A Cross-Sectional Study.

Authors:  Junaura R Barretto; Ney Boa-Sorte; Caian L Vinhaes; Hayna Malta-Santos; Jessica Rebouças-Silva; Camila F Ramos; Monica A S Torres-Nascimento; Valeria M Borges; Bruno B Andrade
Journal:  Nutrients       Date:  2020-06-02       Impact factor: 5.717

Review 7.  Adaptive immunity: an emerging player in the progression of NAFLD.

Authors:  Salvatore Sutti; Emanuele Albano
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2019-10-11       Impact factor: 46.802

8.  Fatty Liver Caused by Glycogen Storage Disease Type IX: A Small Series of Cases in Children.

Authors:  Catarina Leuzinger Dias; Inês Maio; José Ricardo Brandão; Edite Tomás; Esmeralda Martins; Ermelinda Santos Silva
Journal:  GE Port J Gastroenterol       Date:  2019-03-14

9.  A clinical model to predict fibrosis on liver biopsy in paediatric subjects with nonalcoholic fatty liver disease.

Authors:  Sakil Kulkarni; Nadia Naz; Hongjie Gu; Janis M Stoll; Michael D Thompson; Brian J DeBosch
Journal:  Clin Obes       Date:  2021-06-09

10.  Antifungal Activity of Coumarin Against Candida albicans Is Related to Apoptosis.

Authors:  Chang Jia; Jian Zhang; Lili Yu; Chenglu Wang; Yijia Yang; Xing Rong; Ke Xu; Maoping Chu
Journal:  Front Cell Infect Microbiol       Date:  2019-01-04       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.